Breaking
Saturday, June 13, 2026

Clinical Trials

🇺🇸 FDA Page 2

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.

Showing 13–24 of 380 articles

Critical impact NewsJun 8, 2026

Syndax pipeline update: Revuforj and Niktimvo catalysts to watch

FDA · 8 min

Dr. Sarah Mitchell
High impact NewsJun 8, 2026

$2M Gene Therapy Cures Need a Financing Model

gene therapy · 4 min

Dr. Sarah Mitchell
High impact NewsJun 8, 2026

Precision under pressure: logistics facts shaping nuclear medicine scalability

4 min

Dr. Sarah Mitchell
High impact NewsJun 8, 2026

Why innovation alone is no longer enough in biopharma

4 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Novo Nordisk supply of Wegovy stabilizes as new capacity comes online

FDA · weight loss · 4 min

Dr. Sarah Mitchell
High impact AnalysisJun 7, 2026

Lenacapavir posts 100% HIV prevention in PURPOSE 1: what it means

HIV · 9 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

BioNTech doses first patient in Phase 1 pancreatic cancer mRNA vaccine trial

pancreatic cancer · 5 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

MariTide Phase 2 obesity data show up to 20% weight loss at one year

obesity · 5 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 7, 2026

Novartis remibrutinib wins Phase 3 in CSU: what it means

chronic spontaneous urticaria · 9 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

Danuglipron Phase 3 Watch After Pfizer’s Phase 2b Obesity Win

obesity · 6 min

Dr. Sarah Mitchell
Critical impact AnalysisJun 7, 2026

Novartis remibrutinib wins Phase 3 in chronic spontaneous urticaria

chronic spontaneous urticaria · 8 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Novo Nordisk supply of Wegovy stabilizes as FDA shortage ends

FDA · weight-loss · 5 min

Dr. Sarah Mitchell